Business briefs: Amgen Inc. downsizing 

The biotechnology company, Amgen Inc., plans to cut up to 14 percent of its work force. The Thousand Oaks-based firm said it plans to reduce its work force by 12 percent to 14 percent, or between 2,200 and 2,600 positions, and take with a restructuring charge between $600 million and $700 million. Amgen (AMGN) also lowered its profit guidance because of slimmer-than-expected sales of its anemia drug.

PENNIES

Rising metal prices have prompted lawmakers to consider dropping the zinc from pennies. Jarden Zinc Products (JAH), the government’s sole supplier of "penny blanks," previously fought legislation allowing retailers to round off cash transactions, effectively eliminating the penny. The company has said it would be willing to consider producing blanks in other metals.

About The Author

Staff Report

Staff Report

Bio:
A daily newspaper covering San Francisco, San Mateo County and serving Alameda, Marin and Santa Clara counties.
Pin It
Favorite

Speaking of Business

More by Staff Report

Latest in Business & Real Estate

Sunday, May 27, 2018

Videos

Most Popular Stories

© 2018 The San Francisco Examiner

Website powered by Foundation